George D. Demetri's Insider Trades & SAST Disclosures
George D. Demetri's most recent trade in Blueprint Medicines Corp was a trade of 5,300 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern George D. Demetri.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 5,300 | 5,300 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 2,600 | 8,412 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | George D. Demetri | Director | Sale of securities on an exchange or to another person at price $ 58.60 per share. | 21 Jun 2022 | 10 | 5,812 (0%) | 0% | 58.6 | 586 | Common Stock |
| Blueprint Medicines Corp | George D. Demetri | Director | Purchase of securities on an exchange or from another person at price $ 82.70 per share. | 21 Jun 2022 | 10 | 5,822 (0%) | 0% | 82.7 | 827 | Common Stock |
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,500 | 4,500 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,250 | 5,812 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | George D. Demetri | Director | Sale of securities on an exchange or to another person at price $ 112.15 per share. | 04 Jan 2021 | 758 | 3,562 (0%) | 0% | 112.2 | 85,010 | Common Stock |
| Blueprint Medicines Corp | George D. Demetri | Director | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 22 Sep 2020 | 1,704 | 4,320 (0%) | 0% | 85 | 144,840 | Common Stock |
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 4,500 | 4,500 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 2,250 | 6,024 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | George D. Demetri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 1,312 | 0 | - | - | Restricted Stock Units | |
| Blueprint Medicines Corp | George D. Demetri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 1,312 | 3,774 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges